A US observational study of nearly 7,000 adults with HIV-1 [...]

ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

A European survey of more than 1,900 people living with [...]

Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]